Which Form?
Moderate
consensus
Dosage
Timing
Huberman covers metformin across 5 videos, ranging from blood glucose regulation to a dedicated Journal Club episode. In his Journal Club with Attia, they critically examine metformin studies, particularly the 2014 Banister study and a newer Danish twin study that cast doubt on metformin's survival advantage. In his longevity supplements AMA, Huberman explicitly states he avoids metformin, berberine, and rapamycin for longevity. He also discusses metformin as a glucose-lowering prescription drug in his hunger and satiety episodes, noting its potency but warning about hypoglycemia risks. A guest episode with David Sinclair touches on metformin as part of Sinclair's personal longevity protocol.
See exactly which form each expert takes, why they chose it, and their reasoning with video citations.
Cancel anytime